EMEA-000366-PIP02-09-M06

Key facts

Invented name
Humira
Active substance
adalimumab
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0174/2019
PIP number
EMEA-000366-PIP02-09-M06
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
AbbVie Limited

E-mail: paediatricteam@abbvie.com
Tel. +44 1628925033

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating